Company page

Novo Nordisk A/s Class B

Novo Nordisk A/S Class B is a leading global healthcare company based in Denmark, specializing in diabetes care and hormone replacement therapies. With a market capitalization of approximately 227.3 billion DKK, the company is recognized for its commitment to innovation and improving patient outcomes. Novo Nordisk is publicly traded under the ticker NOVO_B.